Omega-3s Can Slow Down Aging Process
en-GBde-DEes-ESfr-FR

Omega-3s Can Slow Down Aging Process


Many people would like to delay or even stop the aging process. Previous clinical studies have shown that a reduced calorie intake can slow down the aging process in humans. Taking vitamin D or omega-3 fatty acids has also shown promising results in slowing biological aging in animals. However, it was unclear whether these measures would also work in humans.

The therapies previously tested in the DO-HEALTH study led by Heike Bischoff-Ferrari are also associated with a slowing of the aging process. These showed that vitamin D and omega-3 fatty acids, as well as regular physical activity, reduce the risk of infections and falls, and prevent cancer and premature frailty. “These results inspired us to measure the direct influence of these three therapies on the biological aging process in the Swiss DO-HEALTH participants,” says Bischoff-Ferrari, professor of geriatrics and geriatric medicine at the University of Zurich.

Measuring biological and chronological age
One scientific approach to making biological aging measurable is the use of epigenetic clocks. They record chemical modifications of the DNA molecule, known as methylation, and thus quantify the difference between biological and chronological aging. The DO-HEALTH study has now for the first time investigated how sensitively this molecular biological measurement method reacts to targeted treatment.

The team led by Heike Bischoff-Ferrari, in collaboration with Steve Horvath, senior researcher at Altos Labs Cambridge (UK), who developed the watches, investigated the effect of omega-3s and/or vitamin D and/or simple strength training on biological aging in 777 people over the age of 70. Eight different treatment combinations were tested during the three-year study: subjects took 2,000 international units (IU) of vitamin D and/or 1 gram of omega-3 fatty acids (from algae) daily and/or performed 30 minutes of strength training at home three times a week.

Biological age slowed down
When the researchers analyzed the blood samples, they found that taking omega-3 fatty acids slowed down biological aging across several epigenetic clocks by up to four months – regardless of subjects’ gender, age or body mass index. The combination of omega-3, vitamin D and strength training proved to be even more effective, according to one of the four epigenetic clocks used.
“This result extends our previous findings from the DO-HEALTH study, in which these three factors combined had the greatest impact on reducing the risk of cancer and preventing premature frailty over a three-year period, to slowing down the biological aging process,” says Bischoff-Ferrari. Each of these measures works through different mechanisms that complement each other and, when combined, result in a heightened overall effect, according to the study author.

DO-HEALTH as a validation platform
At the same time, the research team draws attention to the limitations of the study. “There is no generally accepted gold standard for measuring biological age,” Bischoff-Ferrari explains. “However, we analyzed the best currently validated epigenetic clocks, which reflect the state of the art.” To further advance the clinical application of biological clocks, Bischoff-Ferrari, together with leading international researchers in the Global Health Span Extension Consortium, plans to use DO-HEALTH and other global intervention studies as a validation platform for novel biomarkers of aging.

The researchers also point out that the sample consists exclusively of Swiss participants and therefore does not represent the global population of older adults aged 70 years and older. In a next step, they plan to extend their analyses to all DO-HEALTH participants – including people from Germany, France, Austria and Portugal – to account for a greater diversity of genetics and lifestyles.

Literature
Heike A. Bischoff-Ferrari et al. Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial. Nature Aging. 3 February 2025. DOI: 10.1038/s43587-024-00793-y

Contact
Prof. Dr. med. Heike A. Bischoff-Ferrari, MPH, DrPH
Geriatrics and Geriatric Medicine
University of Zurich
+ 79 412 29 84

E-mail
DO-HEALTH Trial
The 2157 study participants were randomized into eight different groups to test the individual and combined benefits of the interventions: Group 1 received 2000 IU of vitamin D3 per day (which is more than 200 percent of the amount currently recommended for older adults, 800 IU per day), 1 g of omega-3 fatty acids per day, and a simple home-based exercise program three times per week; Group 2 received vitamin D3 and omega-3 fatty acids; Group 3 received vitamin D3 and the exercise program; Group 4 received omega-3 fatty acids and the exercise program; Group 5 received vitamin D3 only; Group 6 received omega-3 fatty acids only; Group 7 received the exercise program only; and Group 8 received a placebo.

Participants received follow-up phone calls every three months and underwent standardized and comprehensive health and functional assessments, including lifestyle factors such as diet and physical activity, at the study centers at baseline, year 1, year 2, and year 3. The DO-HEALTH cohort and biobank is the largest study of healthy adults aged 70 years and older in Europe and is led by the University of Zurich. The DO-HEALTH study and its international network of researchers have been funded by the EU’s Seventh Framework Program for Research.

The epigenetic measurements were supported by the Swiss National Science Foundation (principal investigator Bischoff-Ferrari).
Regions: Europe, Switzerland, Austria, France, Germany, Portugal, United Kingdom
Keywords: Health, Medical, Science, Life Sciences

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Referenzen

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Wir arbeiten eng zusammen mit...


  • BBC
  • The Times
  • National Geographic
  • The University of Edinburgh
  • University of Cambridge
  • iesResearch
Copyright 2025 by DNN Corp Terms Of Use Privacy Statement